Page 1 of Clinical Trials for 5-Azacitidine, 212 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Phase I 5-Azacytidine Plus VPA Plus ATRA
Last Updated: April 10, 2012
Condition(s): Myelodysplastic Syndrome; Acute Myelogenous Leukemia
2
Completed
Phase I/II 5-Azacytidine Plus VPA Plus ATRA
Last Updated: June 6, 2011
Condition(s): Myelodysplastic Syndrome; Acute Myelogenous Leukemia
3
Active, not recruiting
5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia
Last Updated: September 2, 2011
Condition(s): Chronic Lymphocytic Leukemia; Leukemia
4
Not yet recruiting
Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes
Last Updated: March 28, 2011
Condition(s): Myelodysplastic Syndromes
5
Recruiting
Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine
Last Updated: October 13, 2011
Condition(s): Acute Myeloid Leukemia (AML)
6
Recruiting
A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia
Last Updated: January 17, 2012
Condition(s): Chronic Myelomonocytic Leukemia
7
Active, not recruiting
Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer
Last Updated: October 5, 2011
Condition(s): Non-small Cell Lung Cancer; Squamous Cell Carcinoma of the Head and Neck
8
Active, not recruiting
A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Non-small Cell Lung Cancer
Last Updated: February 24, 2012
Condition(s): Solid Tumors; Non-small Cell Lung Cancer
9
Not yet recruiting
Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
Last Updated: April 2, 2012
Condition(s): Leukemia
10
Recruiting
Azacitidine and CAPOX in Metastatic Colorectal Cancer
Last Updated: March 1, 2012
Condition(s): Colorectal Cancer
11
Recruiting
The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
Last Updated: March 14, 2012
Condition(s): Myelodysplastic Syndrome; Acute Myelogenous Leukemia
12
Recruiting
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
Last Updated: October 6, 2011
Condition(s): Myelodysplastic Syndromes
13
Completed
Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
Last Updated: January 20, 2012
Condition(s): Myelodysplastic Syndrome; Acute Myeloid Leukemia
14
Recruiting
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Last Updated: March 29, 2012
Condition(s): MDS; AML; Solid Tumors; Multiple Myeloma; Non-Hodgkin's Lymphoma; Hodgkin's Disease
15
Recruiting
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Last Updated: November 21, 2011
Condition(s): Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Prolymphocytic Leukemia; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Small Intestine Lymphoma; T-cell Large Granular Lymphocyte Leukemia
16
Terminated
Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Last Updated: April 28, 2011
Condition(s): Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS)
17
Recruiting
5-Azacytidine and Oxaliplatin With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy
Last Updated: May 14, 2012
Condition(s): Advanced Cancer; Solid Tumor; Lymphoma
18
Recruiting
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age
Last Updated: May 1, 2012
Condition(s): Acute Myeloid Leukemia; Acute Myelogenous Leukemia
19
Suspended
Azacitidine and MS-275 in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Last Updated: April 27, 2012
Condition(s): Lung Cancer
20
Completed
Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients
Last Updated: April 14, 2011
Condition(s): Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Leukemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=5-Azacitidine

Page 1 of Clinical Trials for 5-Azacitidine, 212 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About